Anderson, SC, United States of America

Anindya Dasgupta

This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Children's Healthcare of Atlanta, Inc., Emory University, The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anindya Dasgupta. Retrieved from https://idiyas.com/inventor/anindya-dasgupta-0psvsa9b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anindya Dasgupta: Innovator in Cancer Treatment

Introduction

Anindya Dasgupta is a notable inventor based in Anderson, SC (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches to immunotherapy. With a total of 3 patents, Dasgupta's work is paving the way for advancements in medical science.

Latest Patents

Dasgupta's latest patents focus on drug-resistant immunotherapy for the treatment of cancer. The present disclosure is generally related to methods for combining chemotherapy and immunotherapy for the treatment of cancer. These methods also relate to generating a drug-resistant cytotoxic immune cell line and its uses in conjunction with cytotoxic drugs. This innovative approach aims to enhance the effectiveness of cancer treatments and improve patient outcomes.

Career Highlights

Throughout his career, Anindya Dasgupta has worked with prestigious institutions such as Emory University and the UAB Research Foundation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Dasgupta has collaborated with notable individuals in his field, including Harold Trent Spencer and Lawrence S. Lamb. These partnerships have further enriched his research and development efforts in cancer treatment.

Conclusion

Anindya Dasgupta's innovative work in drug-resistant immunotherapy represents a significant advancement in cancer treatment. His contributions are vital to the ongoing efforts to improve therapeutic strategies for patients battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…